When a multi-country distributor makes sense in Africa, and when it costs you the market
The pitch is one relationship instead of fifteen. Whether that is a saving or a mistake has little to do with how many countries are on the list. It depends on which constraint actually binds in your sector — regulatory, logistical or relational — and the answer is different for pharmaceuticals than it is for lubricants.
Every principal who looks seriously at Africa arrives at the same question within a month. There are fifty-four countries. Several of them are small. Managing fifty-four distributor relationships is not a plan, and managing fifteen is barely one. So: can one company cover a region?
Sometimes, and very well. The largest distribution group on the continent operates in forty of the fifty-four countries through a hundred and forty-five operating subsidiaries, and a global pharmaceutical manufacturer appointed a single partner across twenty-five sub-Saharan markets in one agreement. Those are real structures doing real work. Multi-country distribution in Africa is not a fantasy sold to the naive.
But the same structure, offered by a different counterparty for a different product, is the most reliable way we know to end up with one market served and fourteen dormant, no registrations in your name, and a territory you cannot take back without litigation. The difference between those two outcomes is not luck and it is not the quality of the distributor’s intentions. It is structural, and it is knowable before you sign.
1. Four things sold as “multi-country”
The phrase covers four structures that behave nothing like each other. Almost every disappointing regional appointment we have been asked to unwind was one of the lower two, presented as one of the upper two. Establishing which one you are being offered is the first and cheapest piece of diligence available.
The group with owned subsidiaries
A holding company with a separately incorporated, separately licensed operating company in each market. CFAO, owned by Toyota Tsusho, is the clearest example: around €9.1 billion of revenue, 91% of it from Africa, through roughly 145 operating subsidiaries across forty of the continent’s fifty-four countries. What you are buying here is one contract sitting over many local companies — local staff, local licences, local banking, local marketing authorisations. This is the version that works, and it is worth being precise about why: the multi-country part is the contract, not the operation. The operation is still national, because it has to be.
The regional specialist
Genuine depth across a bloc that has something real binding it — usually francophone West Africa, occasionally East Africa. Fewer countries than the first category, often more capability per country. Frequently the better answer for a mid-sized principal, because the group with 145 subsidiaries will not give a modest brand much attention.
The hub exporter
A real, often excellent, business in one market, which also ships to buyers in neighbouring ones. The second-tier countries are export customers, not markets they operate in. There is nothing dishonest about this — it is a legitimate model, and for some products it is the efficient one. The problem is that it is routinely described in the same words as the first category. If your brand is to be registered, marketed and supported in Ghana, a Nigerian distributor who occasionally sells into Ghana is not doing that, and will not start because the agreement says so.
The letterbox
A territory of fifteen countries and an operation in one, taken largely to stop anyone else having it. Sometimes this is opportunism. More often it is optimism that did not survive contact with the second market. Either way, it is identifiable in advance by asking for something very simple: the name, address and headcount of the entity that will hold your product in each named country. A group with subsidiaries answers that in an afternoon.
“For each country in the proposed territory, which legal entity will import, hold the licence, employ the sales people, and carry the receivable?” Four facts per country. A real multi-country distributor has them to hand because they appear in their own management accounts. Everyone else produces a map.
2. Why free trade has not moved the border that matters
The regional pitch usually arrives wrapped in continental integration. The African Continental Free Trade Area is in force, the African Medicines Agency exists, the blocs are harmonising. One territory, one partner, one set of rules. It is worth being clear about what has actually changed, because the gap between the direction of travel and the current state is where a lot of money gets lost.
AfCFTA liberalises tariffs. It does not harmonise approval. The agreement has been in force since the start of 2021, and the Guided Trade Initiative that began in October 2022 has countries trading under it in practice, but the volumes are modest and the exercise is still closer to a proof of concept than a trading regime. Rules of origin remain unagreed for parts of textiles, processed foods and some industrial categories, which means goods in those categories cannot claim preference at all. More to the point for a distribution agreement: a tariff concession changes what you pay at the border. It does not change who is allowed to sell your product on the other side of it.
The African Medicines Agency is real, and it is a recommendation body. Its headquarters in Kigali was inaugurated in November 2024, a Director-General was appointed in June 2025, and the continental harmonisation and safety-surveillance programmes formally transferred to it in January 2026. Under the joint continental evaluation pilot, a first cohort of products was assessed and listed at continental level — twelve of them. What that listing does is facilitate national authorisation. Legal authority to put a medicine on the market in Nigeria still rests with NAFDAC, in Kenya with the Pharmacy and Poisons Board, in Ghana with the FDA, in South Africa with SAHPRA, in Egypt with the EDA. The AMA is a significant institution and it will matter. It does not yet issue a marketing authorisation that crosses a border.
The regional harmonisation schemes are work-sharing, not single approval. ZaZiBoNa in southern Africa, the EAC medicines regulatory harmonisation programme in the east, and the ECOWAS equivalent in the west all reduce duplicated assessment through joint review and reliance on a lead authority. They are genuinely useful and they shorten timelines. All of them preserve national authority over the final decision, and a national authorisation is still issued country by country, usually to a locally licensed holder. Approval timelines across the continent still commonly run somewhere between six and twenty-four months per market.
Integration is reducing the cost of multi-country regulatory work. It is not reducing the count. You still need a holder in each country, you still relabel for each country, and you still have a separate asset in each country that someone owns. Any pitch that treats a region as one regulatory unit is describing a future state, and you would be signing in the present one.
3. The question that decides it
Country count is the wrong variable. The useful question is what the binding constraint is on selling your particular product — the thing that, if it is not solved, nothing else matters. There are three, and each one implies a different answer about territory.
Regulatory-bound
The gating item is a national approval held by a local entity: medicines, vaccines, diagnostics, agrochemicals, veterinary products, many foods. A multi-country distributor saves you almost nothing on this work, because the work does not consolidate — it is n dossiers either way. And it concentrates a lot of risk, because one counterparty now holds your right to sell in every market at once. Multi-country is defensible here only where the counterparty holds its own licences through its own local subsidiaries, which is a short list of groups.
Logistics-bound
The gating item is landed cost and availability: lubricants, industrial consumables, building materials, spare parts. Here geography genuinely has shape. The unit of economics is the corridor, not the country — Mombasa inland to Uganda, Rwanda and eastern DRC; Dar es Salaam to Zambia and the DRC copperbelt; Abidjan and Tema north to the Sahel. A distributor running one regional warehouse against three landlocked markets is doing something a national distributor structurally cannot. This is the strongest honest case for multi-country.
Relationship-bound
The gating item is coverage of a fragmented customer base: fast-moving consumer goods, anything sold through open markets and general trade. The asset is trade credit extended to thousands of small accounts, vans, and a sales force that knows the names. None of that crosses a border. A distributor who is excellent in Nairobi has no advantage whatsoever in Kampala beyond a shorter flight.
4. Sector by sector
The table is the short version. The paragraphs that follow it carry the qualifications, which in several cases reverse the headline.
| Sector | Binding constraint | Multi-country? | The condition |
|---|---|---|---|
| Pharmaceuticals | Regulatory | Only with a subsidiary group | Counterparty holds its own marketing authorisations through locally licensed entities it owns |
| Medical devices | Regulatory, but portable | Often workable | Authorisation stays in your name with a local representative; service coverage is the real test |
| Diagnostics | Regulatory plus service | Regional, not continental | Instrument base needs engineers within a day’s travel |
| FMCG | Relational | Rarely beyond two markets | Modern trade only, or genuinely adjacent cities |
| Automotive parts | Logistical | Yes, corridor-shaped | A real regional warehouse, not a drop-ship arrangement |
| Lubricants | Logistical plus blending | Yes | Blending or filling capacity in-region; bulk freight dominates the economics |
| Construction materials | Logistical and project-led | Follow the customer | Works when your buyer is a multi-country contractor, not because the map is |
| Agricultural inputs | Regulatory and seasonal | No | Per-country registration plus a planting calendar that does not align across latitudes |
| Capital equipment | Volume | Usually the only option | No single country justifies a dedicated partner |
Pharmaceuticals and vaccines
The default answer is no, and the exception is important enough that the default is misleading on its own.
Against it: the marketing authorisation is national and almost always has to be held by a locally licensed entity. A single distributor across fifteen markets means one commercial counterparty controlling your right to sell in all fifteen. If the relationship ends badly, it does not end in one market, it ends everywhere at once, and the re-registration bill arrives fifteen times. This is the single largest concentration of risk available in distribution, and it is routinely taken on without being priced.
For it: Sanofi did exactly this. From October 2021 it appointed Eurapharma, CFAO’s healthcare arm, as exclusive partner for distributing and marketing its medicines and vaccines across twenty-five English- and French-speaking sub-Saharan countries, operating through E.P. DIS. Eurapharma supplies around twenty-three African countries. That is a serious multi-country pharmaceutical appointment by a company with no shortage of alternatives.
What makes it work is not scale in the abstract. It is that the counterparty already holds the licences, in its own subsidiaries, in each of those markets — so the authorisation is still national, still locally held, and the principal is dealing with one group rather than one entity stretched across borders. Reading that deal as “multi-country distribution works in African pharma” is the wrong lesson. The lesson is that it works with a counterparty of that specific shape, and there are perhaps five of them on the continent.
A separate point, often missed: whatever the territory, insist the marketing authorisation sits with you or an affiliate wherever national law permits it. The structures where this is possible vary by country and by product class, and it is the difference between changing a distributor and starting again. Who holds your product registration covers the mechanics.
Medical devices and diagnostics
Structurally friendlier than pharma, for one reason: in a number of regimes the authorisation remains in the manufacturer’s name with a local authorised representative named alongside it, rather than vesting in the distributor. Where that is true, the lock-in that makes pharma dangerous largely disappears, and a multi-country appointment becomes a commercial decision rather than a hostage situation.
The constraint moves instead to service. An installed base of instruments needs engineers, spares and calibration within reach. A distributor covering six countries from one city will cover the one it is in. For consumables and single-use devices this matters much less; for capital diagnostics it is decisive, and the honest version of a regional appointment names which countries get a resident engineer and which get a visit.
Fast-moving consumer goods
The weakest case on the continent, and the one most often attempted.
General trade route-to-market is built from things that do not travel: credit extended to thousands of small retailers who are known personally, a van fleet sized to a specific city’s traffic, merchandisers, and relationships with the wholesalers who actually set the shelf. A distributor’s strength in that model is local by definition. Crossing a border means rebuilding all of it, against incumbents who already have it, with capital that could instead go into deepening the market they already win in.
There are two real exceptions. Modern trade — if you are selling into regional supermarket chains and nothing else, the buying can be regional and a regional partner may match it. And genuine adjacency, where two markets are effectively one trading area; the Nairobi–Kampala axis behaves this way for some categories, as does the Abidjan–Accra corridor. Two adjacent markets is a different proposition from a region.
Automotive parts and lubricants
The best general case, because the economics are corridor-shaped rather than border-shaped. Bulk freight dominates landed cost, and a distributor holding regional inventory against several markets serves landlocked customers that a purely national operator cannot reach at a sensible price. Lubricants add a second argument: where the partner has blending or filling capacity in-region, shipping concentrate or base oil rather than finished goods changes the cost structure for every market behind that plant.
The test is physical. Does the proposed partner operate a warehouse, in a named location, with stock, serving the secondary markets — or do orders from those markets get drop-shipped from your own plant with the distributor taking a margin for the paperwork? The second is not regional distribution, and should not be priced as it.
Construction materials
Here the right territory is usually defined by the customer rather than the map. Large projects are let to contractors who themselves operate across several countries, and a distributor already approved on that contractor’s vendor list carries real value into every market that contractor works in. That is a genuine multi-country argument and it has nothing to do with geography.
The counterweight is conformity. Building products run into national standards regimes and project-specific approvals that do not travel, and the specification work is done locally with local engineers and local consultants. A regional partner who cannot get your product specified in a given country is holding a territory they cannot convert.
Agricultural inputs
Per-country, almost without exception. Registration of crop protection products is national, slow and expensive, and it is tied to trial data generated in that country’s conditions. On top of that, the selling season is set by the planting calendar, which does not align across latitudes — a distributor’s working capital peaks at different moments in Kenya and Zambia, and a single partner must choose which season to fund.
Capital equipment and industrial
The clearest yes. Where a country might absorb three or four units a year, no competent distributor will build a dedicated capability for it, and you should not want them to. A regional partner aggregating six such markets reaches a volume that supports a real technical sales function and a spares holding. This is the category where multi-country is not a compromise but the correct structure.
5. Where it genuinely earns its keep
Set the sector aside for a moment. There are four situations where a regional appointment is right almost regardless of what you sell.
Francophone West Africa
The strongest regional case on the continent, and not for sentimental reasons. The eight UEMOA states share the West African CFA franc, which is pegged to the euro — so there is no currency translation between them and no devaluation risk against your invoice. They share business law through OHADA, so a contract, a security interest and an insolvency behave the same way in each. They share a working language. And Abidjan and Dakar are real regional hubs with the warehousing and freight-forwarding depth to serve the interior. Four separate sources of friction removed at once; nothing else in Africa stacks like that.
The East African corridors
Uganda, Rwanda, Burundi and eastern DRC are landlocked and are supplied through Mombasa or Dar es Salaam whether or not your distribution agreement acknowledges it. Appointing separate national distributors for markets that are physically served from the same port, by the same clearing agents, over the same road, creates an argument about who owns the corridor. Better to recognise the corridor and contract to it.
Low volume per market
If the realistic first-three-year number in a given country will not pay for a distributor’s attention, you cannot buy that attention by appointing someone exclusively. Aggregation is the only way the economics work, and a regional partner at least has a reason to answer the phone.
Your own bandwidth
This is the one principals discount and then regret. Three distributor relationships managed properly — forecasts reviewed, visits made, pricing policed, registrations tracked — outperform twelve managed by an inbox. If you have one export manager covering a continent, a structure that assumes fifteen active relationships is not a plan you are going to execute.
6. Where it reliably goes wrong
The territory is defined as “Africa”
The two most expensive words available. It grants markets nobody has analysed, including ones that will later be worth more than the whole deal, and it makes partial recovery impossible — you cannot take back Nigeria from a territory that was never enumerated. Name the countries. Always.
The three largest markets are treated as part of a region
Nigeria, Egypt and South Africa are each large enough, and different enough, to deserve their own appointment and their own agreement. Nigeria and Egypt have both put foreign suppliers through severe currency and repatriation difficulty in recent years, which changes how a distributor there finances stock and how you should expect to be paid; those are market-specific problems that need a market-specific counterparty. South Africa has its own regulatory system, its own retail structure and its own competitive set, and treating it as the lead market of SADC usually means a South African partner servicing South Africa and calling the rest a region.
Performance is measured in aggregate
A single regional minimum lets three strong markets carry eleven dead ones, indefinitely, with the agreement in good standing throughout. By the time it is obvious, the term has renewed twice and a competitor has taken the markets you were not watching. Country-level minimums are not an administrative detail; they are the only mechanism that makes a regional agreement reviewable.
Sub-distributors are invisible
In practice a regional distributor will appoint someone local in the markets where it has no operation. That is not objectionable in itself — it is how the model works. What is objectionable is not knowing who they are, what margin they take, what they are told about your product, or whether your brand is registered in their name. Approval rights and disclosure cost nothing to ask for at signature and are unobtainable afterwards.
7. A six-question test
Run these before the commercial discussion, not after. If three or more answers are unsatisfactory, the right structure is probably two or three national appointments and a deliberate gap.
- Which entity, in each named country? Name, licence, headcount, warehouse. Not a map, not a “presence”.
- Who will hold the regulatory approval in each country, and can it be us or our affiliate? Where it cannot, you are choosing a regulatory custodian as well as a seller.
- Which two or three markets will carry the economics? If the partner cannot answer, they have not modelled it either.
- What does the partner lose if a secondary market produces nothing? If the answer is nothing, that market will produce nothing.
- Is the constraint on this product regulatory, logistical or relational? Regulatory and relational point to national. Logistical points to the corridor.
- How many relationships can we actually manage? Honestly, with the people currently employed.
8. If you do appoint one
A regional agreement is not a national agreement with more countries in the recital. These are the provisions that decide whether it stays governable.
- A schedule of named countries, never a region or a continent
- Minimum volumes stated per country, in units, not a single aggregate value
- Termination and conversion-to-non-exclusive exercisable country by country, without touching the rest
- Regulatory approvals in your name or an affiliate’s wherever national law permits, with an obligation to sign transfer or release documents on exit
- A defined local presence per country — entity, people, stock — as a condition of keeping that country
- Sub-distributor approval rights, with disclosure of their identity and terms
- Reporting split by country, in units and in sell-out where it exists, monthly
- A review point at twelve and twenty-four months with pre-agreed consequences, so withdrawing a market is a mechanism rather than a dispute
- Granting the full territory at signature because it was asked for as a package
- Accepting “we have partners there” without names
- One aggregate minimum covering every market
- Letting the distributor register the product in its own name across the whole territory at once
- Including Nigeria, Egypt or South Africa in a regional grant without separate thought
- A five-year term because the partner needs it to justify investment, with no country-level break
- Treating a signed regional agreement as market entry in every country named in it
9. What we would usually advise
The structure that survives contact with the continent most often is not a regional appointment and not fifteen national ones. It is to appoint properly in the two or three markets that will carry the economics, and to take a deliberate, time-limited option over the rest — a right of first refusal, or a non-exclusive arrangement with conversion on performance, so a secondary market can be upgraded when it earns it and reassigned when it does not.
That is less tidy than one signature. It costs more management attention in year one. It also leaves you with something to negotiate with in year three, which a fifteen-country exclusive does not. The markets you did not grant are the only leverage you will have when the partner who took everything is performing in one place.
General commercial guidance, not legal or regulatory advice. Regulatory positions and trade-agreement status were researched against primary and institutional sources current in October 2026; several of these regimes are actively changing, and continental integration in particular is moving. Requirements vary by product within a class and by country within a bloc. Take local regulatory and legal advice on any specific product and market before relying on any of this.
We run distributor search and selection across 40+ countries, including the African markets covered here. Where a regional structure is on the table, scoping which countries belong in it is part of the work.